<DOC>
	<DOC>NCT01952548</DOC>
	<brief_summary>This study will test single doses of the study drug in increasing amounts to see if it is safe.</brief_summary>
	<brief_title>Study Comparing the Pharmacokinetics, Pharmacodynamics, and Safety of K-312 in Healthy Adult Volunteers</brief_title>
	<detailed_description />
	<criteria>Subject provides written informed consent before any studyspecific evaluation is performed. Subject is a healthy adult male or a female of nonchildbearing potential between the ages of 18 and 45 years, inclusive. Subject has a body mass index of 18.5 to 32 kg/m2, inclusive. Subject is a woman who is of childbearing potential or is breastfeeding. Subject has the presence of an active or recurring clinically significant cardiovascular, pulmonary, renal, endocrine, hepatic, neurologic, psychiatric, immunologic, hematologic, gastrointestinal, or metabolic disease requiring medical treatment.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>